Pfizer Q3 2026: What is verified and what is not
· rollingout.com · popularity 21/100 · 0 similar stories today
Read the original at rollingout.com →
Summary
Pfizer reported third-quarter results today, that topped Wall Street expectations, and the drugmaker raised its full-year 2026 guidance for both revenue and adjusted earnings per share. How did Pfizer’s Q3 compare with estimates? Revenue came in at $16.6 billion, above the $15.87 billion analysts expected. Adjusted earnings per share were 87 cents, well ahead of […] The post Pfizer Q3 2026: What is verified and what is not appeared first on Rolling Out .
Found in: Rolling Out. Rating basis: single outlet; outlet tier 2 (unlisted); 1 feeds; feed position 1.